Vaughan David Investments LLC IL Acquires 3,934 Shares of UnitedHealth Group Incorporated $UNH

Vaughan David Investments LLC IL raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% in the 4th quarter, HoldingsChannel reports. The firm owned 150,773 shares of the healthcare conglomerate’s stock after purchasing an additional 3,934 shares during the quarter. Vaughan David Investments LLC IL’s holdings in UnitedHealth Group were worth $49,772,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the business. Sarver Vrooman Wealth Advisors acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $25,000. Beacon Financial Strategies CORP acquired a new position in UnitedHealth Group during the 4th quarter valued at about $26,000. Anfield Capital Management LLC grew its position in shares of UnitedHealth Group by 220.0% during the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after buying an additional 55 shares during the period. Joseph Group Capital Management bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $27,000. Finally, Foster Dykema Cabot & Partners LLC raised its position in shares of UnitedHealth Group by 69.4% during the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 34 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth announced it will release second-quarter 2026 results on July 16 and host an investor call the same morning, keeping attention on the company’s upcoming fundamentals and guidance. UnitedHealth Group Announces Earnings Release Date
• Positive Sentiment: UnitedHealth was highlighted as a momentum stock and a “best longevity stock” pick, reflecting improving market sentiment and renewed interest from growth-oriented investors. UnitedHealth Group (UNH) is a Top-Ranked Momentum Stock: Should You Buy?
• Positive Sentiment: Analysts remain constructive, with Erste Group lifting its FY2027 EPS estimate for UNH and maintaining a Buy rating, reinforcing expectations for earnings recovery. MarketBeat analyst update
• Positive Sentiment: The company also announced a dividend hike, adding to the case that management is confident in cash flow and long-term earnings stability. 3 Stocks That Announced Dividend Hikes Amid Geopolitical Tensions
• Neutral Sentiment: Coverage focused on whether UNH’s rebound from a weak 2025 has further room to run after touching a 52-week high; this supports the bullish narrative but is more commentary than a new catalyst. UnitedHealth Group Just Hit a 52-Week High. Is It Too Late to Buy This Soaring Stock?

Analysts Set New Price Targets

UNH has been the topic of several recent research reports. Weiss Ratings upgraded UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 7th. Royal Bank Of Canada raised their price objective on UnitedHealth Group from $361.00 to $400.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. Leerink Partners boosted their price objective on shares of UnitedHealth Group from $345.00 to $400.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. Barclays increased their target price on UnitedHealth Group from $373.00 to $429.00 and gave the stock an “overweight” rating in a report on Tuesday, May 26th. Finally, Mizuho upped their price objective on UnitedHealth Group from $440.00 to $460.00 and gave the stock an “outperform” rating in a research report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $407.17.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the transaction, the chief executive officer directly owned 17,805 shares in the company, valued at approximately $6,320,775. The trade was a 4.30% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group Stock Performance

UNH opened at $405.58 on Friday. The firm has a market capitalization of $368.32 billion, a PE ratio of 30.63, a PEG ratio of 1.64 and a beta of 0.64. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $415.98. The business’s 50-day simple moving average is $359.59 and its 200 day simple moving average is $326.28. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.80 and a current ratio of 0.80.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.76 by $0.47. The business had revenue of $111.65 billion during the quarter, compared to analysts’ expectations of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The firm’s revenue was up 2.0% on a year-over-year basis. During the same period last year, the business earned $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 18.32 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th will be paid a $2.32 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date is Monday, June 15th. UnitedHealth Group’s dividend payout ratio is currently 66.77%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.